For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/psychedelics-for-depression-9984 Summary In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Gerald Maguire explore the emerging role of psychedelics in treating mental health conditions. Listeners will learn about the mechanisms of action of psychedelic therapeutics and gain insights into their effects on the brain and behavior. The program will also review recent clinical trial data on the efficacy of psychedelic treatments for major depressive disorder (MDD), as well as provide expert insights on how to discuss the future of psychedelics with patients. This podcast was recorded and is being used with permission of the presenters. Learning Objectives At the conclusion of this activity, participants should be better able to: Describe the mechanism of action of psychedelic therapeutics Review clinical trial data regarding the use of psychedelic treatments in MDD This activity is accredited for CME/CE Credit This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.75 contact hours (which includes 0.75 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at
[email protected] . Summary of Individual Disclosures Please review faculty and planner disclosures here . Disclosure of Commercial Support This educational activity is not commercially supported. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
